Patent Assignment
Reel/Frame 056505/0871
Assignment of Assignor's Interest
Recorded: 2021-06-10
Pages: 5
Assignor
BROOKS, GREGORY F.
Executed: 2021-05-20
Assignee
AEON BIOPHARMA, INC.
4040 MACARTHUR BOULEVARD, SUITE 310, NEWPORT BEACH, CALIFORNIA, 92660
Covered Properties
(5)
Neurotoxin Compositions for Use in Treating Headache
Patent:
11,826,405 →
Application:
17/006,685 →
Publication:
US 2021/0060144
PCT:
PCT/US2020/048624 ↗
Neurotoxin Compositions for Use in Treating Headache
Application:
62/894,540 →
Neurotoxin Compositions for Use in Treating Headache
Application:
62/950,775 →
Neurotoxin Compositions for Use in Treating Headache
Application:
63/011,168 →
Neurotoxin Compositions for Use in Treating Headache
Application:
63/029,304 →
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 23, 2020
From: BROOKS, GREGORY F.
To: AEON BIOPHARMA, INC.
Reel/Frame 051603/0572 →
Assignment of Assignor's Interest
Jan 30, 2020
From: BROOKS, GREGORY F.
To: AEON BIOPHARMA, INC.
Reel/Frame 051671/0889 →
Assignment of Assignor's Interest
Jun 10, 2021
From: BLUMENFELD, ANDREW M.
To: AEON BIOPHARMA, INC.
Reel/Frame 056505/0832 →
Assignment of Assignor's Interest
Jun 21, 2021
From: BROOKS, GREGORY F.; BLUMENFELD, ANDREW M.
To: AEON BIOPHARMA, INC.
Reel/Frame 056603/0010 →
Assignment of Assignor's Interest
Sep 7, 2021
From: BROOKS, GREGORY F.; BLUMENFELD, ANDREW M.
To: AEON BIOPHARMA, INC.
Reel/Frame 057400/0847 →
Security Interest
Mar 19, 2024
From: AEON BIOPHARMA, INC.
To: DAEWOONG PHARMACEUTICAL CO., LTD.
Reel/Frame 066830/0138 →
Security Interest
Mar 20, 2024
From: AEON BIOPHARMA, INC.; AEON BIOPHARMA SUB, INC.
To: DAEWOONG PHARMACEUTICAL CO., LTD.
Reel/Frame 066847/0164 →
Assignment of Assignor's Interest
Mar 22, 2024
From: AEON BIOPHARMA, INC.
To: AEON BIOPHARMA SUB, INC.
Reel/Frame 066876/0628 →
Patent Security Agreement
Jan 22, 2026
From: AEON BIOPHARMA SUB, INC.
To: DAEWOONG PHARMACEUTICAL CO., LTD.
Reel/Frame 074476/0932 →
Release of Security Interest in Patent Collateral
Jan 22, 2026
From: DAEWOONG PHARMACEUTICAL CO., LTD.
To: AEON BIOPHARMA, INC.; AEON BIOPHARMA SUB, INC.
Reel/Frame 074476/0802 →